An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.
Clinical trial NCT00343226 · COMPLETED
Trial details
- NCT number
- NCT00343226
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2005-04-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.